166 related articles for article (PubMed ID: 2211649)
1. Identification of the ATP-binding domain of vaccinia virus thymidine kinase.
Black ME; Hruby DE
J Biol Chem; 1990 Oct; 265(29):17584-92. PubMed ID: 2211649
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase.
Black ME; Hruby DE
J Biol Chem; 1992 May; 267(14):9743-8. PubMed ID: 1577811
[TBL] [Abstract][Full Text] [Related]
3. Characterization of three essential residues in the conserved ATP-binding region of Epstein-Barr virus thymidine kinase.
Wu CC; Hsu TY; Chen JY
Biochemistry; 2005 Mar; 44(12):4785-93. PubMed ID: 15779905
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding.
Black ME; Hruby DE
J Biol Chem; 1992 Apr; 267(10):6801-6. PubMed ID: 1551887
[TBL] [Abstract][Full Text] [Related]
5. Expression and single-step purification of enzymatically active vaccinia virus thymidine kinase containing an engineered oligohistidine domain by immobilized metal affinity chromatography.
Franke CA; Hruby DE
Protein Expr Purif; 1993 Apr; 4(2):101-9. PubMed ID: 8471843
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
Suzutani T; Davies LC; Honess RW
J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
[TBL] [Abstract][Full Text] [Related]
7. Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.
El Omari K; Solaroli N; Karlsson A; Balzarini J; Stammers DK
BMC Struct Biol; 2006 Oct; 6():22. PubMed ID: 17062140
[TBL] [Abstract][Full Text] [Related]
8. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase.
Kussmann-Gerber S; Kuonen O; Folkers G; Pilger BD; Scapozza L
Eur J Biochem; 1998 Jul; 255(2):472-81. PubMed ID: 9716390
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a binding factor that interacts with the sequences upstream of the vaccinia virus thymidine kinase gene.
Wilson EM; Edbauer C; Hruby DE
Virus Genes; 1988 Oct; 2(1):31-48. PubMed ID: 3227643
[TBL] [Abstract][Full Text] [Related]
10. Expression vector pT7:TKII for the synthesis of authentic biologically active RNA encoding vaccinia virus thymidine kinase.
Wilson EM; Franke CA; Black ME; Hruby DE
Gene; 1989 Apr; 77(1):69-78. PubMed ID: 2744489
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided active-site-directed modeling of the herpes simplex virus 1 and human thymidine kinase.
Folkers G; Trumpp-Kallmeyer S; Gutbrod O; Krickl S; Fetzer J; Keil GM
J Comput Aided Mol Des; 1991 Oct; 5(5):385-404. PubMed ID: 1663155
[TBL] [Abstract][Full Text] [Related]
12. Substrate binding is a prerequisite for stabilisation of mouse thymidine kinase in proliferating fibroblasts.
Posch M; Hauser C; Seiser C
J Mol Biol; 2000 Jul; 300(3):493-502. PubMed ID: 10884346
[TBL] [Abstract][Full Text] [Related]
13. Effect on substrate binding of an alteration at the conserved aspartic acid-162 in herpes simplex virus type 1 thymidine kinase.
Black ME; Rechtin TM; Drake RR
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1521-7. PubMed ID: 8757995
[TBL] [Abstract][Full Text] [Related]
14. Site-directed mutagenesis in the active site of the herpes simplex virus type 1 thymidine kinase gene.
Fetzer J; Folkers G; Müller I; Keil GM
Virus Genes; 1993 Jun; 7(2):205-9. PubMed ID: 8396286
[TBL] [Abstract][Full Text] [Related]
15. Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity.
Liu QY; Summers WC
Virology; 1988 Apr; 163(2):638-42. PubMed ID: 2833027
[TBL] [Abstract][Full Text] [Related]
16. Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase.
Rechtin TM; Black ME; Mao F; Lewis ML; Drake RR
J Biol Chem; 1995 Mar; 270(13):7055-60. PubMed ID: 7706243
[TBL] [Abstract][Full Text] [Related]
17. Effect of in vitro mutations in a vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus.
Coupar BE; Boyle DB; Both GW
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2299-309. PubMed ID: 2821171
[TBL] [Abstract][Full Text] [Related]
18. Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior.
Cheng YC
Biochim Biophys Acta; 1976 Dec; 452(2):370-81. PubMed ID: 188465
[TBL] [Abstract][Full Text] [Related]
19. Artificial mutants generated by the insertion of random oligonucleotides into the putative nucleoside binding site of the HSV-1 thymidine kinase gene.
Dube DK; Parker JD; French DC; Cahill DS; Dube S; Horwitz MS; Munir KM; Loeb LA
Biochemistry; 1991 Dec; 30(51):11760-7. PubMed ID: 1661147
[TBL] [Abstract][Full Text] [Related]
20. Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.
Prichard MN; Keith KA; Johnson MP; Harden EA; McBrayer A; Luo M; Qiu S; Chattopadhyay D; Fan X; Torrence PF; Kern ER
Antimicrob Agents Chemother; 2007 May; 51(5):1795-803. PubMed ID: 17325220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
